FDA Approves GlaxoSmithKline And Theravance COPD Drug
By Toni Clarke Shares of Theravance were up 8.7 percent at $34.00 in midday trading on the Nasdaq. Earlier in the day they
fda approves glaxosmithkline theravance copd drug toni clarke shares theravance percent  midday trading nasdaq early day